You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 11, 2025

Details for Patent: 3,900,481


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 3,900,481
Title: Derivatives of pyrrolidine and piperidine
Abstract:Certain compounds in which a carbon atom of a pyrrolidine or piperidine ring is bonded directly or through a methylene group to the nitrogen of a substituted benzamido group, and their pharmaceutically acceptable salts, are found to be active as antiarrhythmic agents.
Inventor(s): Banitt; Elden H. (Woodbury, MN), Bronn; William R. (St. Paul, MN)
Assignee: Riker Laboratories, Inc. (Northridge, CA)
Application Number:05/457,099
Patent Claim Types:
see list of patent claims
Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 3,900,481

Introduction

United States Patent 3,900,481, titled "Derivatives of Pyrrolidine and Piperidine," is a patent that was granted for novel compounds belonging to the pyrrolidine and piperidine classes. This article will delve into the details of the patent's scope, claims, and the broader patent landscape surrounding these compounds.

Background of the Patent

The patent, filed under the publication number US3900481A, involves the synthesis and characterization of new derivatives of pyrrolidine and piperidine. These compounds are significant in various fields, including pharmaceuticals and organic chemistry, due to their potential biological activities and synthetic versatility[1].

Structural Differences

The compounds described in this patent differ structurally from those previously disclosed in other patents, such as U.S. Pat. No. 3,719,687. These differences are crucial as they define the novelty and uniqueness of the inventions claimed in the patent[1].

Claims of the Patent

The claims section of a patent is critical as it defines the scope of protection granted to the inventor. For US3900481A, the claims would typically include:

  • Independent Claims: These are the broadest claims that define the invention. They would specify the novel compounds, their structural features, and any specific methods of synthesis or use.
  • Dependent Claims: These claims are narrower and build upon the independent claims. They might include specific examples of compounds, particular methods of preparation, or specific uses of the compounds.

The clarity and breadth of these claims are essential for determining the patent's scope and ensuring that the invention is adequately protected[3].

Scope of the Patent

The scope of a patent is determined by the language used in the claims. For US3900481A, the scope would encompass:

  • Novel Compounds: The patent protects the specific derivatives of pyrrolidine and piperidine that are described.
  • Synthesis Methods: Any unique methods of synthesizing these compounds that are detailed in the patent.
  • Uses: If the patent specifies particular uses for these compounds, such as in pharmaceutical applications, these uses would also be within the scope of the patent.

The scope is crucial for understanding what is protected and what is not, thereby avoiding potential infringement issues[3].

Patent Landscape

The patent landscape for pyrrolidine and piperidine derivatives is complex and dynamic. Here are some key points:

  • Prior Art: The patent references prior art, such as U.S. Pat. No. 3,719,687, indicating that the field is well-established but continuously evolving.
  • Competing Patents: Other patents in the same field might cover similar or related compounds, methods, or uses. Understanding these competing patents is essential for navigating the intellectual property landscape.
  • Litigation and Enforcement: The history of patent litigation in this field can provide insights into how similar patents have been enforced and challenged. For instance, changes in patent law, such as those introduced by the Leahy-Smith America Invents Act (AIA), can impact how patents are granted and litigated[4].

Impact of Patent Law Changes

Changes in patent law, such as those introduced by the AIA, can significantly affect the scope and enforcement of patents. For example:

  • Leahy-Smith America Invents Act (AIA): This act introduced several changes, including limiting the number of defendants in a lawsuit and requiring more uniform terminology for software-related patents. These changes can influence how patents are filed, examined, and litigated[4].

Determining Inventorship

Correctly determining inventorship is crucial for the validity and enforceability of a patent. In the U.S., patent law requires that only the "true and only" inventors be listed on the patent application. This involves identifying who conceived the idea and reduced it to practice, which can sometimes be a complex and contentious issue[5].

Practical Implications

For businesses and researchers working with pyrrolidine and piperidine derivatives, understanding the scope and claims of US3900481A is vital. Here are some practical implications:

  • Freedom to Operate: Ensuring that any new research or development does not infringe on the claims of this patent is essential.
  • Licensing and Collaboration: If the patented compounds or methods are necessary for a project, licensing agreements or collaborations with the patent holder may be required.
  • Innovation: The patent's disclosure can also serve as a foundation for further innovation, as researchers can build upon the disclosed compounds and methods to create new inventions.

Statistics and Industry Insights

The impact of patents like US3900481A on the broader industry can be significant. For example:

  • Patent Litigation: The increase in patent infringement lawsuits, particularly in the software and pharmaceutical sectors, highlights the importance of clear and enforceable patents. From 2000 to 2011, the number of patent infringement lawsuits increased, with software-related patents accounting for a significant portion of this increase[4].
  • Patent Quality: Metrics such as independent claim length and count can provide insights into patent scope and quality. Narrower claims are often associated with a higher probability of grant and a shorter examination process[3].

Key Takeaways

  • Novel Compounds: US3900481A protects novel derivatives of pyrrolidine and piperidine.
  • Scope and Claims: The patent's scope is defined by its claims, which include the novel compounds, synthesis methods, and specific uses.
  • Patent Landscape: The patent landscape for these compounds is complex, with prior art, competing patents, and changes in patent law affecting the field.
  • Inventorship: Correctly determining inventorship is crucial for patent validity.
  • Practical Implications: Understanding the patent's scope is essential for freedom to operate, licensing, and innovation.

FAQs

Q: What are the key structural differences between the compounds in US3900481A and those in prior patents? A: The compounds in US3900481A differ structurally from those disclosed in other patents, such as U.S. Pat. No. 3,719,687, which is crucial for defining their novelty and uniqueness.

Q: How does the Leahy-Smith America Invents Act (AIA) impact patents like US3900481A? A: The AIA introduced changes that can affect how patents are filed, examined, and litigated, including limiting the number of defendants in a lawsuit and requiring more uniform terminology for certain types of patents.

Q: Why is determining inventorship important for patents? A: Correctly determining inventorship is essential for the validity and enforceability of a patent, as it ensures that only the "true and only" inventors are listed on the patent application.

Q: What metrics can be used to measure patent scope? A: Metrics such as independent claim length and count can provide insights into patent scope and quality, with narrower claims often associated with a higher probability of grant and a shorter examination process[3].

Q: How can businesses ensure they do not infringe on patents like US3900481A? A: Businesses should conduct thorough freedom-to-operate analyses to ensure that their research or development does not infringe on the claims of existing patents.

Sources

  1. US3900481A - Derivatives of pyrrolidine and piperidine - Google Patents
  2. U.S. Patent and Trademark Office (USPTO) | USAGov
  3. Patent Claims and Patent Scope - SSRN
  4. Assessing Factors That Affect Patent Infringement Litigation - GAO
  5. Determining Inventorship for US Patent Applications - Oregon State University

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 3,900,481

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 3,900,481

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Argentina 210990 ⤷  Try for Free
Australia 7957875 ⤷  Try for Free
Belgium 827354 ⤷  Try for Free
Canada 1054602 ⤷  Try for Free
Czechoslovakia 209846 ⤷  Try for Free
Switzerland 618425 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 6 of 6 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.